ℹ️
🇬🇧
Search
Search for people relevant for "MCP1"
MCP1
Person
Class
Person
Publication
Programmes
PharmDr. Martin Andrš
External person at Faculty of Medicine in Hradec Králové
20 publications
Publications
publication
In silico library screening to find novel anticancer agent with chemosensitizing properties: focus on targeting ataxia telangiectasia and Rad3 related kinase
2024 |
Faculty of Medicine in Hradec Králové
publication
2,6-Disubstituted 7-(naphthalen-2-ylmethyl)-7H-purines as a new class of potent antitubercular agents inhibiting DprE1
2023 |
Faculty of Pharmacy in Hradec Králové
publication
7-Azaindole, 2,7-diazaindole, and 1H-pyrazole as core structures for novel anticancer agents with potential chemosensitizing properties
2022 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Clinical Candidates Targeting the ATR-CHK1-WEE1 Axis in Cancer
2021 |
Publication without faculty affiliation
publication
Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy
2020 |
Faculty of Medicine in Hradec Králové
publication
Fork Cleavage-Religation Cycle and Active Transcription Mediate Replication Restart after Fork Stalling at Co-transcriptional R-Loops
2020 |
Central Library of Charles University
publication
Novel quinazolin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity
2019 |
Faculty of Medicine in Hradec Králové
publication
Purin-6-one and pyrrolo[2,3-d]pyrimidin-4-one derivatives as potentiating agents of doxorubicin cytotoxicity
2018 |
Faculty of Medicine in Hradec Králové
publication
Novel caffeine derivatives with antiproliferative activity
2016 |
Faculty of Medicine in Hradec Králové
publication
Small Molecules Targeting Ataxia Telangiectasia and Rad3-Related (ATR) Kinase: An Emerging way to Enhance Existing Cancer Therapy
2016 |
Publication without faculty affiliation
Load more publications (10)
Loading network view...